-
Entity
-
Individual
-
Location
-
C/O Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
-
Summary
-
The estimated net worth of Mark A. Glickman is at least $46K dollars as of June 7, 2024. Mark A. Glickman is the Director of NeuroBo Pharmaceuticals, Inc. and owns shares of NeuroBo Pharmaceuticals, Inc. (NRBO) stock worth about $30.5K. Mark A. Glickman is the Co-Chief Executive Officer of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $15.5K.